Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.02 - $3.92 $3,636 - $7,056
-1,800 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$3.74 - $6.7 $4,114 - $7,370
1,100 Added 157.14%
1,800 $6,000
Q3 2021

Nov 09, 2021

SELL
$6.05 - $10.41 $1,530 - $2,633
-253 Reduced 26.55%
700 $4,000
Q2 2021

Aug 12, 2021

SELL
$6.66 - $10.92 $5,041 - $8,266
-757 Reduced 44.27%
953 $9,000
Q1 2021

May 14, 2021

BUY
$4.59 - $18.74 $7,848 - $32,045
1,710 New
1,710 $15,000
Q1 2018

May 11, 2018

SELL
$4.05 - $6.46 $2,025 - $3,230
-500 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$3.88 - $6.96 $1,940 - $3,480
500
500 $2,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $375M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.